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Colony morphology ontologyBackground: One of the major concerns of the biomedical community is the increasing prevalence of
antimicrobial resistant microorganisms. Recent ﬁndings show that the diversiﬁcation of colony
morphology may be indicative of the expression of virulence factors and increased resistance to antibiotic
therapeutics. To transform these ﬁndings, and upcoming results, into a valuable clinical decision making
tool, colony morphology characterisation should be standardised. Notably, it is important to establish the
minimum experimental information necessary to contextualise the environment that originated the
colony morphology, and describe the main morphological features associated unambiguously.
Results: This paper presents MorphoCol, a new ontology-based tool for the standardised, consistent and
machine-interpretable description of the morphology of colonies formed by human pathogenic bacteria.
The Colony Morphology Ontology (CMO) is the ﬁrst controlled vocabulary addressing the speciﬁcities of
the morphology of clinically signiﬁcant bacteria, whereas the MorphoCol publicly Web-accessible
knowledgebase is an end-user means to search and compare CMO annotated colony morphotypes. Its
ultimate aim is to help correlate the morphological alterations manifested by colony-forming bacteria
during infection with their response to the antimicrobial treatments administered.
Conclusions: MorphoCol is the ﬁrst tool to address bacterial colony morphotyping systematically and
deliver a free of charge resource to the community. Hopefully, it may introduce interesting features of
analysis on pathogenic behaviour and play a signiﬁcant role in clinical decision making.
Database URL: http://morphocol.org.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Human infections involve a complex intertwined interplay of
microorganisms. Understanding these interactions as well as the
continuously emerging mechanisms of antimicrobial resistance
are pressing goals in clinical microbiology.
Recent technologies, such as the enzyme-linked immunosor-
bent assay (ELISA), the polymerase chain reaction (PCR) and the
matrix-assisted laser desorption/ionisation time of ﬂight mass
spectrometry (MALDI-TOF MS) have boosted the identiﬁcation
and characterisation of clinically signiﬁcant bacteria [1–3].
However, the research community is manifesting a renewed inter-
est in traditional culture-based strategies like colony morphologycharacterisation as more immediate, ﬁrst-term means of decision
support [4,5].
Alterations in the morphology of the microbial colonies,
reﬂected in macroscopically observable features such as form,
colour, opacity, size and texture, may support bacteria proﬁling
under changing and often stressful environments [6–8]. Notably,
these morphological features are being increasingly documented
in clinical settings as potential evidences of the expression of viru-
lence factors [9–12] and increased resistance to antibiotic thera-
peutics [13–15]. For example, mucoid morphotypes [16,17] and
small colony variants [18–20] are recognised as markedly resistant
to a wide range of conventional antibiotics, and are often related to
multi-resistant strains. Therefore, an increasing number of scienti-
ﬁc studies are documenting morphotypes of clinically signiﬁcant
bacteria.
In principle, colony morphology characterisation is a simple
procedure and it is fairly easy to integrate into the analytical pipe-
line of any laboratory. Colony morphology is described through
naked-eye observation and using a magnifying glass, and classiﬁed
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However, experimental design and morphological annotation
should be consistent in order to allow the systematic comparison
of morphotypes across experiments (and laboratories), species,
diseases and clinical samples. Colony morphologies vary widely,
depending on the particular behaviour of the microbial species
under different test conditions (e.g. different colonisation sites, or
antibiotic agents with different modes of action). Also, the mor-
phological traits exhibited by the colonies may be signiﬁcantly
affected by the procedures taken to isolate and grow the bacteria
[21]. Thus, it is very important to establish the minimum set of
information to be part of the morphotype description and to
employ harmonised vocabulary in both the biological contextual-
isation and the morphological characterisation of the observed
colony.
Scientiﬁc literature is the main source of morphotypes, where
they are often presented as exempliﬁcative ﬁgures of what the
researchers observed and are described informally. The fact that
the description of colony morphologies does not yet follow prede-
ﬁned rules of annotation nor makes use of controlled vocabulary
hampers the automated classiﬁcation, integration and inter-
pretation of such data.
Researchers are in need of new resources and tools geared to
systematically analyse morphotypes, across infections, body loca-
tions, antimicrobial treatments and a number of other conditions
of clinical relevance. Multiple ontologies have been proposed in
the domain of phenotypes. Some are specialised in the character-
isation of species (typically, model organisms), such as the
Mammalian Phenotype ontology (MP) [22], the Worm Phenotype
ontology (WPO) [23], the Plant ontology (PO) [24] and the
Human Phenotype ontology (HPO) [25]. Others, like the
Phenotype and Trait ontology (PATO) [26], are focused on integrat-
ing phenotypes across species, and reuse anatomy and process
ontologies.
This paper presents the rationale of a novel ontological frame-
work in support of the characterisation of the colony morphology
of clinically signiﬁcant bacteria. The Colony Morphology
Ontology (CMO) is introduced as an integrative resource for theFig. 1. General workﬂow of bacterial proﬁling. Bacteria provided from samples are cultiva
included. To perform colony morphology characterisation, bacteria from cultures is plated
10 main morphological features: form, margin, sheath, type of surface, texture, consis
subjected to bacterial proﬁling using other methods, such as antimicrobial susceptibilitsystematic, transparent and unambiguous characterisation of col-
ony morphology traits in support of clinical diagnosis. CMO sup-
ports the MorphoCol database, a public Web repository of
pathogenic bacterial morphotypes (http://morphocol.org). The
aim of this repository is to enable the macroscopic observation of
morphotypes and the comparison of the morphological ‘‘output’’
of the species in different scenarios (e.g. antibiotic therapeutics
and body localisation).
The originality of this work lays on addressing colony morpho-
typing in a systematic, harmonised and computerised way.
Although still in its infancy, MorphoCol aims to pave the way to
the development of advanced clinical decision making applica-
tions, which may use morphological features as immediate indica-
tors of microbial behaviour (Fig. 1). These indicators can be used to
guide more sophisticated (time-consuming and costly) analyses,
such as proteome and transcriptome analyses. Also, they may be
used to construct decision support models that help clinicians in
determining or anticipating what may be expected in terms of a
given microbial species resistance and resilience in a clinical inci-
dent. To the best of our knowledge this is the ﬁrst public repository
documenting bacterial colony morphology systematically.
Currently, the system documents respiratory infection traits. In
the future, it will cover for other major infections regarding the uri-
nary tract, bloodstream, chronic wounds, osteomyelitis and bio-
material-associated infections. Thus, MorphoCol will be of aid to
the wider community of researchers and clinicians working in
clinical microbiology.2. Design and implementation
2.1. Considerations in ontology design
The CMO aims to characterise the main features of the morphol-
ogy of bacterial colonies. Since most of the data is widespread in
scientiﬁc literature, a curation pipeline based on expert manual
annotation was implemented (Fig. 2). The documents are compiled
through PubMed keyword-based searches combining terms
related to morphological descriptions and bacterial colonies. Theted and further characterised using several methods in which colony morphology is
and grown onto solid media. Further, colonies are observed and characterised using
tency, opacity, size and colour. Likewise, colony morphotypes can be isolated and
y and virulence characterisation.
Fig. 2. An overview of the literature curation pipeline of MorphoCol. Colony morphotype curation starts with document retrieval via PubMed. Once all relevant information
has been ﬂagged, curators annotate the morphotypes using morphological features of colonies using CMO and PATO controlled vocabularies, and link morphotypes to the
corresponding phenotypic and molecular data. MorphoCol search engine enables users to retrieve and compare morphologies, ranking results according to keywords of
interest and grouped by bacterial species.
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abstracts and the download of the potentially relevant full-texts.
Most of the contents are retrieved from the sections Materials &
Methods and Results & Discussion (including the captions of
existing ﬁgures and tables) of the reviewed documents.
It is equally important to identify the morphological descrip-
tions as it is to characterise the biological context from where
the morphotypes emerged. Most of the work of curators is centred
on the preparation of an harmonised vocabulary that may support
the systematic and comprehensive description of the morpho-
types, namely: (1) collection of the terms commonly used by
authors of clinical, microbiological and medical studies in the
characterisation of colony morphology; (2) analysis of these
textual descriptors, evaluating the appropriateness of the asso-
ciated semantics and identifying the common name and synonyms
of each concept according to overall concordance and our expertise
in the ﬁeld; and (3) manual validation of the descriptive ability
of the set of concepts gathered against published descriptions of
morphotypes.
Literature curation accounted for more than one hundred
different terms, which were ﬁltered out considering the exclusion
criteria below:
– terms with no clear deﬁnition (for example, ‘‘normal colony’’;
‘‘atypical morphology’’, ‘‘irregular shaped’’, and ‘‘normal size’’);
– terms referring to characteristics of bacteria-forming colony, i.e.
characteristics of the bacteria that form the colony rather
than the morphological features of the colony (for example,
‘‘rod-shaped bacteria’’);
– derived terms (for example, ‘‘semi-ﬂuffy’’, ‘‘semi-dry’’, ‘‘degree
of colour’’, ‘‘non-mucoid’’, ‘‘slightly rhizoid’’, ‘‘marginally
convoluted’’);
– infrequent terms, i.e. those apparently used by only one author
or research group.
Then, the remaining terms were checked for deﬁnition inconsis-
tencies and term synonyms. Typically, the most used term waschosen as the main descriptor of the morphological feature and
the other related terms were associated as synonyms. As a result,
the structure of the CMO encompassed a total of 7 main categories
and 33 sub-categories.
Harmonised and manual annotation guarantees the high qual-
ity of the morphotypes in MorphoCol repository. Likewise, it
enables the search and comparison of morphotype according to
various aspects of morphological and biological characterisations.2.2. CMO format
The CMO was developed following the basic principles of the
Open Biomedical Ontologies (OBO) Foundry [27]. In particular,
the organisation of the CMO was based on the following main
criteria:
– CMO is restricted to the morphological characterisation of
bacterial colonies and, therefore, it contains just model concepts
and relations that are relevant to the representation of colony
data;
– CMO should be used for annotating data in databases and for
textual documentation and as such, it should be understandable
to people and unambiguously interpreted by software;
– CMO development follows a pragmatic approach that grants the
ability to integrate new morphological descriptors as they arise
without affecting the existing ontological structure;
– any bacterial colony morphology should be comprehensively
described by a combination of CMO instances;
– whenever possible, CMO terms are cross-referenced to entries
on other ontologies covering for phenotypic characterisation.
The ontology was constructed using the OBO-Edit editor, an
open source platform that allows the editing of OBO-alike
ontologies (http://oboedit.org/) [28]. Five pre-deﬁned OBO tags
were used to represent the CMO terms, including id, name,
synonym, def and xref.
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MorphoCol is a publicly Web-accessible knowledgebase that
documents bacterial colony morphotypes, as comprehensively as
possible, in order to enable the search and comparison of morpho-
types across species (and strains) and conditions (namely, diseases
and colonisation sites). Currently, the main source of information is
scientiﬁc literature and manual curation grants the high quality of
the data available. The curation pipeline (Fig. 2) will be gradually
incorporating automatic procedures, namely text mining pro-
cesses, now that we have in hand an appropriate terminological
resource and the minimum set of information necessary to com-
prehensively describe a morphotype. Likewise, the knowledgebase
will enable the direct submission of morphotype data by authors,
promoting a close interaction with the community.
MorphoCol server runs on a CentOS platform (version 5.6) with
Apache HTTP server (version 2.2.22), MySQL Community Server
(version 5.1.58) and PHP 5.5.3. Apache, MySQL and PHP technology
are open-source and platform-independent software. Moreover,
MySQL supports multi-threading and multi-user environments,
and thus it is well-suited to support (increasing) real-world data-
base usage. Currently, the Web server and all parts of the database
are hosted at the Centre of Biological Engineering of the University
of Minho, Portugal.Fig. 3. Examples of colony morphologies exhibiting features that the ﬁrst version of
the CMO did not consider: (A) sheath, enveloping part or structure after the margin
that surrounds the colony; dual type of textures, (B) smooth and wrinkled, (C)
smooth and rough, and (D) rough and wrinkled, described from the periphery to the
centre. Black bar = 1 mm.3. Results and discussion
Colony morphotyping is a common technique used in microbio-
logical studies of varied purposes. It should be emphasised that
this study does not propose any colony features. The colony
morphology features mentioned and described are commonly
accepted by the microbiological community and they can be traced
back to as early as papers published decades ago [29–31].
3.1. CMO structure and contents
The validation of the CMO terms against published morphologi-
cal descriptions showed that all terms included in the ontology
structure were valid, but pointed out some additional considera-
tions as follows: Pseudomonas aeruginosa colonies exhibit an
enveloping part or structure after the margin that surrounds the
colony, which is referred to as ‘sheath’ (Fig. 3A); colonies can exhi-
bit more than one type of surface, e.g. P. aeruginosa colonies can
exhibit surfaces with smooth and rough zones (Fig. 3B), smooth
and wrinkled zones (Fig. 3C), or wrinkled and rough zones
(Fig. 3D). To enhance its descriptive abilities, the initial structure
of the CMO was extended to a total of 10 main categories and 37
sub-categories (Fig. 4).
An important issue whilst deﬁning the organisation of the CMO
was the ability to perform updates without causing major changes
in the structure. To this end, the high level nodes of the ontology
represent the general concepts behind the morphological features
more frequently discussed in the literature, including ‘form’, ‘mar-
gin’, ‘type of surface’, ‘texture’, ‘sheath’, ‘opacity’, ‘elevation’, ‘con-
sistency’, ‘size’ and ‘colour’. The following subsections introduce
these concepts, explaining the semantics adopted by the CMO
and discussing the semantic inconsistencies and ambiguities found
in the literature.
3.1.1. Form
The term ‘form’ is commonly used to describe the whole conﬁg-
uration of a colony. For example, ‘‘. . . overall surface shape (convex,
crater, lobulated, radial, radioumbilicated, radio-umbonated,
peaked, rugose, segmented-rugose, segmented-umbilicated,
umbilicated, umbilicated with irregular edge, umbilicated withheaped-up irregular edge, or umbonated).’’ [32], or to differentiate
colonies with certain characteristics, such as ‘‘. . . two distinct
colony morphology variants that switched between a transparent
form, facilitating adherence and carriage, and an opaque form that
poorly adhered. . .’’ [33]. So, in the CMO, the term ‘colony form’
(CMO:0000001) is deﬁned as the geometrical conﬁguration of the
colony – ‘‘a morphological quality inhering in a colony by virtue
of having a conﬁguration’’.
3.1.2. Margin
The description of the margin of the colony, also referred to as
edge or border, is typically based on the characteristics of the
colony circumference. For example, ‘‘Colony type 2 was hard, more
orange in colour, non-rhizoid or only slightly rhizoid, and had
irregular edges and convex growth form. Colony type 3 had round
edges, and smooth, yellowish appearance.’’ [34], ‘‘‘fried egg’ SCVs,
with translucent edges surrounding a smaller elevated. . .’’ [19],
‘‘other colonies (approximately 60% of the total) were smaller with
somewhat rough edges’’ [35]. In the CMO, the term ‘colony margin’
(CMO:0000002) represents the conﬁguration of the limiting border
of the colony and is described as ‘‘a morphological quality inhering
in a colony by virtue of having a limit zone’’.
3.1.3. Sheath
The description of ‘colony sheath’ is not common in colony
morphology observation. However, this structure is often present
in P. aeruginosa colonies, which are clinically recurrent, and it is
quite variable (Fig. 3). Based on our expertise, this may be a
valuable element in the description of colony differentiation. So,
it was included in the CMO (CMO:0000005) and deﬁned as ‘‘a
morphological quality inhering in a colony by virtue of having a
closely enveloping part or structure after the margin and around
the colony’’.
Fig. 4. Structure of the CMO with deﬁnitions of some terms directly imported or adapted from the PATO.
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As abovementioned, some bacterial species can form colonies
with more than one type of texture at the surface (Fig. 3B–D). As
such, a new category, named ‘type of surface’ (CMO:0000003),
was added to the ontology to describe the type of textures
or irregularities exhibited by the colony surface. Notably,
‘homogeneous surface’ (CMO:0000023) is a surface with just one
type of texture, and ‘heterogeneous surface’ (CMO:0000024), is a
surface that presents more than one type of texture.3.1.5. Texture
Colony texture, also referred to as surface or roughness, is a fea-
ture very common in morphological descriptions. Its importance
arises from experimental evidence that rough colonies are often
associated with key pathogenic phenomena, such as augmented
virulence potential [36,37].
In the literature, we may ﬁnd examples of general texture
descriptions applied to colony morphology such as: ‘‘PA14 lasRmutant formed a ﬂat, smooth colony as compared to the wrinkled
wild-type phenotype’’ [36], ‘‘the ST variant formed colonies that
were smaller and had a rough, wrinkled, and dry surface appear-
ance compared to the smooth, larger WT colonies’’ [38] and ‘‘. . .
type I (wrinkled, purple, dry and irregular giant cristae; n = 8), II
(wrinkled, purple, dry and volcanolike; n = 6), (. . .) V (smooth, pale,
mucoid and raised circles; n = 3), VI (smooth, pale, mucoid and
even glistening; n = 2). . .’’ [39]. This feature may also be used to
describe the form of the colonies. For example, ‘‘. . . overall surface
shape (convex, crater, lobulated, radial, radio-umbilicated, radio-
umbonated, peaked, rugose, segmented-rugose, segmented-
umbilicated, umbilicated, umbilicated with irregular edge,
umbilicated with heaped-up irregular edge, or umbonated)’’ [32].
And, often enough, the types of texture rough andwrinkled are used
as synonymous or as discriminating characteristics [37,38,40].
The CMO addresses this conceptual ambiguity by deﬁning the
terms ‘wrinkled’ and ‘rough’ in accordance to the interpretation
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expertise. The term ‘colony texture’ (CMO:0000004) denotes the
presence or absence of irregularities on colony surface. When
irregularities are present, the form is depicted as ‘wrinkled colony
texture’ (CMO:0000027), and if the vertical irregularities are large
or small it is classiﬁed as ‘rough colony texture’ (CMO:0000026). A
surface showing no irregularities is described as ‘smooth colony
texture’ (CMO:0000025).
3.1.6. Elevation
Typically, the term ‘elevation’ describes the form of growth of
the colony observed from a side perspective. For example,
‘‘Colony type 1 was rhizoid and ﬂat with yellow centre. Colony type
2 was hard, more orange in color, non-rhizoid or only slightly
rhizoid, and had irregular edges and convex growth form.’’ [34].
In the CMO, the terms ‘colony elevation’ (CMO:0000007) and
‘colony form’ (CMO:0000001) are perfectly differentiated, that is
one corresponds to the side perspective of colony form and the
other describes the overall geometric colony conﬁguration,
respectively.
3.1.7. Consistency
The term ‘consistency’ is frequently referred as the wetness or
mucoidy of the colony [33,37]. The characterisation of colony con-
sistency gained renewed importance due to the impact of mucoid
colonies in cystic ﬁbrosis lung disease [41–43]. For example, ‘‘. . .
characterisation of two Burkholderia cenocepacia sequential isolates
displaying different morphotypes (mucoid vs. non-mucoid) iso-
lated from a CF patient. . .’’ [44], ‘‘. . . P. aeruginosa PDO300 showed
a nonmucoid colony morphology. . .’’ [45] and ‘‘. . . type I (wrinkled,
purple, dry and irregular giant cristae; n = 8) (. . .) IV (wrinkled,
pale, semi-dry and volcanolike; n = 2), V (smooth, pale, mucoid
and raised circles; n = 3). . .’’ [39]. Similarly to what happens with
the term ‘texture’ (CMO:0000004), the term ‘colony consistency’
(CMO:0000008) is often described as a form characteristic [32].
In the CMO, the terms ‘colony form’ and ‘colony consistency’ were
separated and ‘colony consistency’ was deﬁned as ‘‘a physical
quality inhering in a colony by virtue of having density, ﬁrmness,
or viscosity’’.
3.1.8. Opacity
Opacity has been described as an important colony feature in
different pathogenic morphotypes. For instance, in the case of
Streptococcus pneumonia colonies ‘‘. . . two distinct colony morphol-
ogy variants that switched between a transparent form, facilitating
adherence and carriage, and an opaque form that poorly
adhered. . .’’ [33] and in the case of Pseudomonas ﬂuorescens colo-
nies, ‘‘. . . The original isolate formed thick opaque colonies. . .’’,
‘‘. . . After three days of growth in liquid KB medium, ﬂat and
translucent colonies were found. . .’’ [9]. Therefore, the term ‘colony
opacity’ (CMO:0000006) was included in the CMO and deﬁned as
‘‘an optical quality which obtains by virtue of the ability of the
mass of the colony to absorb visible light’’.
3.1.9. Size
The feature ‘size’ is a well-recognised trait in colony character-
isation. For instance: ‘‘. . . strain 43895OR is also similar to the rdar
strains of Salmonella enterica serovar Typhimurium in characteris-
tics such as colony size. . .’’, ‘‘. . . Escherichia coli strain 43895OR
forms a larger colony. . .’’ [46], ‘‘. . . Temperature-induced SCVs were
<1 mm in colony size. . .’’ [47] and ‘‘. . . Analysing the persisting
bacteria revealed a high phenotypic diversity, showing normal,
small and very small colonies. . .’’ [48].The signiﬁcance of the size description arises from the associa-
tion between the appearance of small colonies and increased
antibiotic resistance [19,49]. However, it has conceptual gaps. For
instance, Haussler and colleagues [50] considered that P. aerugi-
nosa small colonies are those that have 1–3 mm of diameter. In
contrast, several other authors study P. aeruginosa small colonies
without any assumption about the diameter range of the colony.
Additionally, this deﬁnition of size is highly taxon-dependent. For
instance, the dimension of a small colony of P. aeruginosa, in
general deﬁned as below 3 mm, does not correspond to the
dimension of a small colony of Staphylococcus aureus, typically
deﬁned as below 1 mm. In the CMO, the child terms of ‘colony size’
(CMO:0000009) were deﬁned in a taxon-independent manner such
that the term ‘small colony size’ (CMO:0000045) denotes ‘‘a size
quality of a colony by having a physical dimension or extension
or magnitude nearly one-tenth less than the size of the wild-type
colony’’ and the term ‘large colony size’ (CMO:0000046) denotes
colonies exceeding this threshold.
Diameter measurements are also frequently used to character-
ise the size of the colony. For instance, ‘‘. . . The following features
of colony morphology were recorded: colony size (measured in
mm by ruler). . .’’ [33] and ‘‘. . . cells of the rdar strains were
reported to reach colony diameters of 6 cm. . .’’ [46]. In the CMO,
the term ‘colony diameter’ (CMO:0000047) was included as a child
term of ‘colony size’ (CMO:0000009) and deﬁned as the distance
between two equidistant points of the margin or sheath.
Typically, colony diameter is calculated manually using a rule.
The use of image software tools, such as ImageJ [51], could be of
assistance (systematic and fast large-scale calculation), but issues
relating to region segmentation and size computing methods need
to be discussed ﬁrst.
3.1.10. Colour
The chromogenesis or colour exhibited by bacterial colonies is
very important when describing clinical morphotypes because it
is associated with the differential production of various pigments
[52,53]. Some examples of colour description applied to colony
morphology are: ‘‘. . . certain strains of Salmonella that displayed
a red and dry colony phenotype. . .’’; ‘‘. . . the white variants do
not revert back to a dry, red phenotype. . .’’ [46], ‘‘. . . StNMSm
(straw-colored, nonmucoid, and smooth) morphotypes exhibited
decreased frequency of pyocyanin overproduction. . .’’ [52] and
‘‘Colony type 3 had round edges, and smooth, yellowish appear-
ance. Type 4 colonies were white or light yellow, smooth and
spreading on the agar with irregular shape.’’ [34]. In the
CMO, the term ‘colony colour’ (CMO:0000010) was deﬁned as
‘‘a composite chromatic quality composed of hue, saturation and
intensity parts’’. A diverse and automatic pallete of colours could
be incorporated under the term ‘colour’, but we chose to focus
on the colours that have already been documented in the
literature. The CMO includes these ‘‘basic’’ colours, notably ‘white’
(CMO:0000048), ‘black’ (CMO:0000049), ‘grey’ (CMO:0000050),
‘brown’ (CMO:0000051), ‘yellow’ (CMO:0000052), ‘red’
(CMO:0000053), ‘orange’ (CMO:0000054), ‘green’ (CMO:0000055),
‘blue’ (CMO:0000056), ‘pink’ (CMO:0000057) and ‘violet’
(CMO:0000058).
3.2. PATO as ontological reference
The analysis of existing phenotypic ontologies, such as PATO
[26], MP [22], WPO [23], PO [24] and HPO [25], revealed a number
of terms in common. However, PATO is the only ontology that
provides taxon-independent and general phenotypic descriptors,
which is one of the main requirements of the CMO design.
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terms of PATO (Fig. 4) were adapted to ﬁt the CMO domain. For
example, the term ‘circular’ in PATO is deﬁned as ‘‘a shape quality
inhering in a bearer by virtue of the bearer’s being such that every
part of the surface or the circumference is equidistant from the
center’’ and in CMO is deﬁned as ‘‘a form feature inhering in a
colony by virtue to present a conﬁguration of a circumference or
a circle due to any point of the edge be equidistant from the
center’’. So, the labels of the CMO terms were altered to prevent
any confusion about the CMO and PATO terms and their
deﬁnitions. For example, ‘circular colony form’ (CMO:0000011),
‘smooth colony texture’ (CMO:0000025), ‘transparent colony
opacity’ (CMO:0000030), ‘ﬂat colony elevation’ (CMO:0000034),
‘viscous colony consistency’ (CMO:0000041), and ‘colony colour’
(CMO:0000010). The adaptation of terms and deﬁnitions was also
motivated by differences in the organisation of the PATO and the
CMO, and affected 14 terms. For instance, the term ‘lobate’
(PATO:0001367) in the PATO is ‘‘a surface feature shape quality
inhering in a bearer by virtue of the bearer’s having deeply
undulating edges forming lobes’’ whilst the term ‘lobate colony
margin’ (CMO:0000019) in the CMO is not a surface feature shape
quality, but rather a margin feature quality.
A total of 10 CMO terms did not ﬁnd any correspondence with
PATO due to semantics differences. For example, the term ‘small’
(PATO:0000587) is described in the PATO as ‘‘a size quality which
is relatively low’’, but in the scope of bacterial colonies the
deﬁnition of ‘small colony size’ (CMO:0000045) is more speciﬁc,
i.e. ‘‘a physical magnitude 10 times smaller than the diameter of
the wild-morphotype’’.
3.3. Availability
The CMO ontology ﬁles, including terms, deﬁnitions and
relationships, are freely available at the MorphoCol Web knowl-
edgebase for bacterial colony morphotypes (http://morphocol.
org) and the portal of the international consortium Minimum
Information About a Bioﬁlm Experiment (MIABiE) (http://miabie.
org).
3.4. Web application – MorphoCol knowledgebase
The volume of phenotypic data on bacterial colonies is growing
considerably due to the use of high-throughput experimental
procedures and analytical methods, and the impressive ability of
bacteria to diversify under several environmental conditions. The
variety of morphotypes within and across species is great, and
requires expert knowledge on the formation of colonies and on
the pathogenic bacteria under study in order to describe the
observed morphological features comprehensively. Computer
applications in assistance of phenotypic annotation and analysis
are therefore considered pivotal to manage and integrate data in
an amenable, systematic and accurate way. In particular, biomedi-
cal ontologies are the key to standardise terminology and describe
relevant morphological features unambiguously.
The immediate application of the CMO is the sharing of current
understanding of the variation of colony morphology in microbial
infection among domain experts, both clinicians and researchers.
Furthermore, the CMO may be of help to information retrieval
applications, providing vocabulary and taxonomy that can be used
for query expansion and semantic searching in this domain.
The MorphoCol knowledgebase is supported by the CMO and
aims to help manage the fast proliferation of information about
colony morphology. Currently, documentation efforts are focused
on morphotypes exhibited by pathogenic bacteria causing res-
piratory infections, one of the most prevalent types of infection
worldwide. Typically, respiratory human pathogens, such asP. aeruginosa and S. aureus, differentiate when colonising the
human lungs [54]. For instance, several colony morphologies, such
as the P. aeruginosa mucoid morphotype [42] and small colony
variants of S. aureus [55], have been correlated to cystic ﬁbrosis
development. The identiﬁcation of these and other clinically sig-
niﬁcant colony morphotypes is of tremendous importance because
colony observation is quite immediate and costless when
compared to state-of-the-art identiﬁcation methods. Even without
pinpointing the strains involved, morphotype comparison may
provide insights on the stage of infection (acute, intermediate or
chronic) and the resistance and virulence levels to be expected
from the bacteria.
As such, colony morphologies are to be documented with
various descriptive metadata (Fig. 5), including information about
the experimental conditions and the morphology observed.
Experimental information is related to the ‘‘circumstances’’ in
which colonies are collected, e.g. the species and strains involved,
the type of culture that bacteria are coming from (e.g. planktonic or
bioﬁlm), and the plating conditions in which bacteria were allowed
to grow in solid media to form colonies (e.g. medium, time of
growth, temperature, respiratory conditions). The description of
such information is of upmost importance since experimental con-
ditions signiﬁcantly affect the colony morphogenesis [21]. The
morphological annotation is supported by the CMO. The experi-
ment is proﬁled in terms of authorship (institution and person of
contact), the data scope, the date of execution, and derived
publications. The morphotype data record is manually veriﬁed in
order to ensure its quality and thus allow clinicians and research-
ers to consider such data in their analyses and the formulation of
new hypotheses.
4. Conclusions and challenges
Several authors have documented colony morphologies in
clinical settings and have shown that morphological features
may be indicative of underlying microbial cues, and most notably,
of resistance and virulence responses [55,56]. Over the years, this
research team has analysed a large number of colony morphologies
generated by clinically signiﬁcant bacteria and developed expertise
on colony observation and annotation. This led to the development
of a specialised method of analysis that aims to deliver useful
inputs to more elaborated (and costly) studies, and assistance to
clinical decision making [21]. The development of the CMO, the
ﬁrst ever controlled vocabulary on colony morphology, and the
MorphoCol knowledgebase are considered an important step
forward for enabling the standardised and systematic annotation
of morphotypes. For the ﬁrst time, there is a knowledgebase
dedicated to the management of data related to colony morpho-
types, including morphological data and experimental metadata.
This knowledgebase provides the basic means to enquire and
compare the visual manifestations of bacterial evolution
and adaptation processes across pathogenic microorganisms and
infections.
In the short term, efforts will be focused on extending the
description of the pathogenic potential of colony-forming bacteria,
particularly regarding the expression of virulence factors, such as
the ability to form bioﬁlms, the production of toxins and
quorum-sensing molecules. Moreover, the query tool will be
complemented by a customisable comparison tool that looks for
morphological similarities across species, infection sites and
diseases. Therefore, the tool will provide insights on the most
relevant traits of colony morphology under a given clinical sce-
nario, which may be useful as predictive features of the virulence
potential and resistance proﬁle of bacteria causing the infection.
MorphoCol welcomes contributions from any research group
working on the characterisation of clinically relevant morphotypes,
Fig. 5. The ﬂowchart of the MorphoCol annotation process. Colony data annotation consists of the curation of morphological, experimental metadata and details followed by
manual conﬁrmation. After validation, morphotype data record is available online for information retrieval and formulation of new hypotheses.
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Currently, the system documents respiratory infection traits. In
the near future, it will cover for other major infections regarding
the urinary tract, bloodstream, chronic wounds, osteomyelitis
and biomaterial-associated infections. Thus, MorphoCol will be of
aid to the wider community of researchers and clinicians working
in clinical microbiology.
Given that the ultimate aim is to rationalise morphological and
biological associations within and across species, and across infec-
tions, molecular, proteomic, transcriptomic and genomic proﬁles
will be a key, future asset. For instance, proteomic approaches
may support the identiﬁcation of morphotypes-biomarkers and
future target sites for new drugs whilst transcriptomic approaches
may provide snapshots of gene expression during infection devel-
opment and microbial response to antimicrobial treatments. These
data will validate the correlation of morphotypes to resistance and
virulence cues, and enhance our understanding about the different
responses of pathogens to antimicrobial therapies in acute and
chronic infections. Altogether, these data will provide valuable
inputs to clinical research and decision-making.Competing interests
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